✦ LIBER ✦

Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial

✍ Scribed by Westin, Jason R.; Thompson, Michael A.; Cataldo, Vince D.; Fayad, Luis E.; Fowler, Nathan; Fanale, Michelle A.; Neelapu, Saatva; Samaniego, Felipe; Romaguera, Jorge; Shah, Jatin; McLaughlin, Peter; Pro, Barbara; Kwak, Larry W.; Sanjorjo, Perpetua; Murphy, William A.; Jimenez, Camillo; Toth, Bela; Dong, Wenli; Hagemeister, Fredrick B.

Book ID: 121784051
Publisher: Elsevier
Year: 2013
Tongue: English
Weight: 513 KB
Volume: 13
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2012.11.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized Controlled Trial of Zoledroni

Randomized Controlled Trial of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Nonmetastatic Prostate Cancer

✍ SMITH, MATTHEW R.; EASTHAM, JAMES; GLEASON, DONALD M.; SHASHA, DANIEL; TCHEKMEDY 📂 Article 📅 2003 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 106 KB

Re: Randomized Controlled Trial of Zoled

Re: Randomized Controlled Trial of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Nonmetastatic Prostate Cancer

📂 Article 📅 2003 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 64 KB

Re: Randomized Controlled Trial of Zoled

Re: Randomized Controlled Trial of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Nonmetastatic Prostate Cancer

✍ Pitts, W. Reid 📂 Article 📅 2003 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 57 KB

Risedronate for prevention of bone miner

Risedronate for prevention of bone mineral density loss in patients receiving high-dose glucocorticoids: a randomized double-blind placebo-controlled trial

✍ C. C. Mok; K. H. Tong; C. H. To; Y. P. Siu; K. M. Ma 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 156 KB

Phase III Randomized, Placebo-Controlled

Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Risedronate for the Prevention of Bone Loss in Premenopausal Women Undergoing Chemotherapy for Primary Breast Cancer

✍ Van Poznak, C.H.; Brown, J.E. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Randomized, Double-Blinded, Placebo-Cont

Randomized, Double-Blinded, Placebo-Controlled, Trial of Risedronate for the Prevention of Bone Mineral Density Loss in Nonmetastatic Prostate Cancer Patients Receiving Radiation Therapy Plus Androgen Deprivation Therapy

✍ Choo, Richard; Lukka, Himu; Cheung, Patrick; Corbett, Tom; Briones-Urbina, Rosar 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 255 KB